Clinical Trial Update: Post-COVID-19 Chronic Fatigue Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating post-COVID-19 chronic fatigue syndrome has completed; the update notes completion without providing efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: ClinAmygate | Conditions: Post-COVID-19 Syndrome, Post-COVID Syndrome | Phase 4 | Status: COMPLETED